Researchers at Barcelona’s Center for Genomic Regulation, in collaboration with the Cold Spring Harbor Laboratory in the U.S., have identified a new oncogene, p63, responsible for a type of skin cancer and that promotes the abnormal growth of stem cells. The finding was made public to coincide with the eve of World Cancer Day

STAFF | FEBRUARY 4TH, 2011

A study by the Gene Expression and Cancer research group of the Vall d'Hebron Oncology Institute (VHIO) in Barcelona has identified genetic markers that indicate which cells are responsible for a tumor’s onset and recurrence. The possession of this information is useful in determining what treatments do or do not eliminate these cells

STAFF | DECEMBER 14TH, 2010

The technique used in the operation, carried out at the Hospital Clinic of Barcelona, does not require abdominal incisions, reducing the patient’s pain and recovery time. This is the first time in Europe and second in the world that such an operation is performed on a human. The patient was discharged three days after the operation

STAFF | DECEMBER 10TH, 2010

In a subgroup of tumors that appear in the colon, stomach and uterus cancer cells hijack a group of anti-tumor molecules within the nucleus, preventing them from maturing and performing their function in the cell, according to an international team led by Manel Esteller, researcher of the Bellvitge Institute of Biomedical Research in Barcelona.

STAFF | OCTOBER 20TH, 2010